23rd February 2021
Four promising healthcare start-ups have proven the viability of their innovations and business plans in a competitive EIT Health Gold Track workshop in February.
These start-ups have been selected to progress to the next stage of the programme and receive individualised and tailored mentoring by leading industry players, to support them in achieving commercial success.
The EIT Health Gold Track programme identifies healthcare start-ups with the greatest potential to significantly scale their innovations and helps these start-ups to achieve their business goals against an accelerated timeline. Selected companies spend up to a year working with handpicked mentors, who are industry experts, successful entrepreneurs and seasoned investors.
Start-ups that are invited to apply to Gold Track workshop pitch to the programme’s Expert Council and compete by convincing at least one council member to commit to mentoring them. Once committed, the Expert Council members work with the company to assess the start-up’s current status, identify gaps and set priorities. Start-ups commit to achieving ambitious milestones with the continuous support of their dedicated mentor. At the end of each work phase, start-ups report back to the Gold Track Expert Council to discuss achievements, adjust goals and assess eligibility to progress to the next phase of support. Start-ups that prove their potential can undergo as many as three phases of goal-oriented mentorship, for a total of one year of Gold Track support.
The start-ups selected to return for the next Gold Track stage are:
Phagomed: Creating a new generation of antibacterials by developing endolysins and phages as therapeutics.
Minovia: Using mitochondrial cell therapy to bring life-changing, meaningful therapies to people affected with mitochondrial diseases.
Scenic Biotech: Focused on identifying genetic modifiers for drug intervention.
NovaSight: Using eye tracking and AI, to revolutionize pediatric vision care.
Find out more about Gold Track here.